Sony To Use iPS Cell Analyzer To Plunge Into Medical-Device Industry
This article was originally published in PharmAsia News
Executive Summary
Sony plans to draw on its digital-electronics expertise to enter the medical-equipment business in a big way by reducing the amount of time it takes to develop cultured cells into commercialized regenerative medicine.
Sony plans to draw on its digital-electronics expertise to enter the medical-equipment business in a big way by reducing the amount of time it takes to develop cultured cells into commercialized regenerative medicine. Sony developed technology that allows it to monitor the movements of cardiac myocytes and other iPS cells in reaction to introduction of a substance, without the need for dyes or cutting them. Prototypes of the device are being tested at Kyoto University before Sony attempts to market them. (Click here for more - a subscription may be required
)
"Sony Develops iPS Cell Analyzer" - Nikkei (Japan) (11/22/2013)